These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13618254)

  • 21. Physiological and histochemical observations on the adult liver fluke, Fasciola hepatica L.; feeding.
    STEPHENSON W
    Parasitology; 1947 Jul; 38(3):123-7. PubMed ID: 20255195
    [No Abstract]   [Full Text] [Related]  

  • 22. Physiological and histochemical observations on the adult liver fluke, Fasciola hepatica L.; the excretory system.
    STEPHENSON W
    Parasitology; 1947 Jul; 38(3):140-4. PubMed ID: 20255197
    [No Abstract]   [Full Text] [Related]  

  • 23. High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia.
    Elliott TP; Kelley JM; Rawlin G; Spithill TW
    Vet Parasitol; 2015 Apr; 209(1-2):117-24. PubMed ID: 25771931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bithionol (Actamer) is effective in the "liver fluke test" against Fasciola hepatica].
    LIENERT E
    Z Tropenmed Parasitol; 1962 Oct; 13():338-41. PubMed ID: 13930569
    [No Abstract]   [Full Text] [Related]  

  • 25. Maturation and probable gynogenesis in the liver fluke, Fasciola hepatica L.
    SANDERSON AR
    Nature; 1953 Jul; 172(4368):110-2. PubMed ID: 13072592
    [No Abstract]   [Full Text] [Related]  

  • 26. Physiological and histochemical observations on the adult liver fluke, Fasciola hepatica L; survival in vitro.
    STEPHENSON W
    Parasitology; 1947 Jul; 38(3):116-22. PubMed ID: 20255194
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of groups in the molecule of 2:3-dihydro-3-ketobenzo-1: 4-thiazine on its effect on liver fluke (Fasciola hepatica) in vitro.
    MACKIE A; RAEBURN J
    Br J Pharmacol Chemother; 1952 Jun; 7(2):219-22. PubMed ID: 14954119
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental infection of liver flukes, Fasciola hepatica and Fascioloides magna, in Bison (Bison bison).
    Foreyt WJ; Drew ML
    J Wildl Dis; 2010 Jan; 46(1):283-6. PubMed ID: 20090045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A kymographic study of the action of drugs on the liver fluke (Fasciola hepatica).
    CHANCE MR; MANSOUR TE
    Br J Pharmacol Chemother; 1949 Mar; 4(1):7-13. PubMed ID: 18124426
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of low temperature on the eggs of the common liver fluke (fasciola hepatica) in beef livers.
    WADE LL
    Am J Vet Res; 1952 Jul; 13(48):345-7. PubMed ID: 12976631
    [No Abstract]   [Full Text] [Related]  

  • 31. A 31P-nmr study of the intact liver fluke Fasciola hepatica.
    Mansour TE; Morris PG; Feeney J; Roberts GC
    Biochim Biophys Acta; 1982 Dec; 721(4):336-40. PubMed ID: 7159598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of Fasciola hepatica and F. gigantica in the endemic area of Guilan, Iran: Relationships between zonal overlap and phenotypic traits.
    Ashrafi K; Valero MA; Peixoto RV; Artigas P; Panova M; Mas-Coma S
    Infect Genet Evol; 2015 Apr; 31():95-109. PubMed ID: 25602718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver fluke (Fasciola hepatica) infection in cattle in Northern Ireland: a large-scale epidemiological investigation utilising surveillance data.
    Byrne AW; McBride S; Lahuerta-Marin A; Guelbenzu M; McNair J; Skuce RA; McDowell SW
    Parasit Vectors; 2016 Apr; 9():209. PubMed ID: 27079910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasciola hepatica: the effects of neuropharmacological agents upon in vitro motility.
    Holmes SD; Fairweather I
    Exp Parasitol; 1984 Oct; 58(2):194-208. PubMed ID: 6148259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiological and histochemical observations on the adult liver fluke, Fasciola hepatica L.; egg-shell formation.
    STEPHENSON W
    Parasitology; 1947 Jul; 38(3):128-39. PubMed ID: 20255196
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the carbohydrate metabolism of the liver fluke Fasciola hepatica.
    MANSOUR TE
    Biochim Biophys Acta; 1959 Aug; 34():456-64. PubMed ID: 13853798
    [No Abstract]   [Full Text] [Related]  

  • 37. The fine morphology of the mitochondria from parenchymal cells in the liver fluke (Fasciola hepatica, L).
    BJORKMAN N; THORSELL W
    Exp Cell Res; 1962 Aug; 27():342-6. PubMed ID: 13869613
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification and differentiation of Fasciola hepatica and Fasciola gigantica using a simple PCR-restriction enzyme method.
    Rokni MB; Mirhendi H; Mizani A; Mohebali M; Sharbatkhori M; Kia EB; Abdoli H; Izadi S
    Exp Parasitol; 2010 Feb; 124(2):209-13. PubMed ID: 19769969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current Threat of Triclabendazole Resistance in Fasciola hepatica.
    Kelley JM; Elliott TP; Beddoe T; Anderson G; Skuce P; Spithill TW
    Trends Parasitol; 2016 Jun; 32(6):458-469. PubMed ID: 27049013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for high genetic diversity of NAD1 and COX1 mitochondrial haplotypes among triclabendazole resistant and susceptible populations and field isolates of Fasciola hepatica (liver fluke) in Australia.
    Elliott T; Muller A; Brockwell Y; Murphy N; Grillo V; Toet HM; Anderson G; Sangster N; Spithill TW
    Vet Parasitol; 2014 Feb; 200(1-2):90-6. PubMed ID: 24360656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.